Q2 FY2026 Earnings
Financial report interval: 2025.10.01 - 2025.12.31
Overview: Mesoblast(MESO) the Revenue is 28.73 M (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.03B--
0.02B--
+0.01B--%
EBIT
TBA--
-0.01B--
----
EPS
TBA--
-0.07--
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf